PRM3
geneOn this page
Summary
PRM3 (protamine 3, HGNC:13732) is a protein-coding gene on chromosome 16p13.13, encoding Protamine-3 (Q9NNZ6). Protamines substitute for histones in the chromatin of sperm during the haploid phase of spermatogenesis.
Predicted to enable DNA binding activity. Predicted to be involved in flagellated sperm motility. Predicted to be located in chromosome and nucleus. Predicted to be part of nucleosome. Predicted to be active in cytoplasm.
Source: NCBI Gene 58531 — RefSeq curated summary.
At a glance
- GWAS associations: 8
- Clinical variants (ClinVar): 28 total
- MANE Select transcript:
NM_021247
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:13732 |
| Approved symbol | PRM3 |
| Name | protamine 3 |
| Location | 16p13.13 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000178257 |
| Ensembl biotype | protein_coding |
| Entrez | 58531 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000327157
RefSeq mRNA: 1 — MANE Select: NM_021247
NM_021247
CCDS: CCDS76821
Canonical transcript exons
ENST00000327157 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001230959 | 11273199 | 11273629 |
Expression profiles
Bgee: expression breadth ubiquitous, 115 present calls, max score 96.05.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0665 / max 59.5432, expressed in 5 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 156243 | 0.0572 | 5 |
| 207756 | 0.0061 | 3 |
| 156244 | 0.0032 | 2 |
Top tissues by expression
129 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 96.05 | gold quality |
| left testis | UBERON:0004533 | 94.20 | gold quality |
| right testis | UBERON:0004534 | 93.88 | gold quality |
| testis | UBERON:0000473 | 93.40 | gold quality |
| sural nerve | UBERON:0015488 | 66.05 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 58.50 | gold quality |
| cerebellar cortex | UBERON:0002129 | 58.31 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 58.11 | gold quality |
| cerebellum | UBERON:0002037 | 57.72 | gold quality |
| left uterine tube | UBERON:0001303 | 49.33 | gold quality |
| bone marrow | UBERON:0002371 | 47.03 | gold quality |
| right lung | UBERON:0002167 | 46.09 | gold quality |
| stromal cell of endometrium | CL:0002255 | 43.50 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 43.10 | gold quality |
| granulocyte | CL:0000094 | 42.74 | silver quality |
| right uterine tube | UBERON:0001302 | 42.43 | silver quality |
| duodenum | UBERON:0002114 | 42.37 | gold quality |
| cortical plate | UBERON:0005343 | 41.42 | gold quality |
| monocyte | CL:0000576 | 41.41 | gold quality |
| rectum | UBERON:0001052 | 41.26 | gold quality |
| endometrium | UBERON:0001295 | 41.19 | gold quality |
| right ovary | UBERON:0002118 | 40.97 | gold quality |
| myometrium | UBERON:0001296 | 40.95 | gold quality |
| leukocyte | CL:0000738 | 40.94 | gold quality |
| right frontal lobe | UBERON:0002810 | 40.05 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 39.76 | gold quality |
| fallopian tube | UBERON:0003889 | 39.60 | gold quality |
| mucosa of stomach | UBERON:0001199 | 39.43 | silver quality |
| bone marrow cell | CL:0002092 | 39.21 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 38.74 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-134144 | yes | 31.34 |
| E-ANND-3 | no | 0.32 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): AP1, DNMT1, ZHX2
Literature-anchored findings (GeneRIF, showing 1)
- Mutations in the protamine locus may be an infrequent cause of male infertility. (PMID:19602509)
Cross-species orthologs
1 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Prm3 | ENSMUSG00000050058 |
Protein
Protein identifiers
Protamine-3 — Q9NNZ6 (reviewed: Q9NNZ6)
Alternative names: Sperm protamine P3
All UniProt accessions (1): Q9NNZ6
UniProt curated annotations — full annotation on UniProt →
Function. Protamines substitute for histones in the chromatin of sperm during the haploid phase of spermatogenesis. They compact sperm DNA into a highly condensed, stable and inactive complex.
Subcellular location. Nucleus. Chromosome.
Similarity. Belongs to the protamine P3 family.
RefSeq proteins (1): NP_067070* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR026077 | PRMP3 | Family |
UniProt features (8 total): compositionally biased region 3, chain 1, region of interest 1, modified residue 1, sequence variant 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9NNZ6-F1 | 58.43 | 0.00 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 95
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 54 (showing top):
GSE45365_CD8A_DC_VS_CD11B_DC_IFNAR_KO_MCMV_INFECTION_UP, GSE45365_NK_CELL_VS_CD8A_DC_DN, GSE45365_NK_CELL_VS_CD11B_DC_UP, GOBP_CHROMOSOME_ORGANIZATION, GOBP_MALE_GAMETE_GENERATION, GOBP_CHROMOSOME_CONDENSATION, YGACNNYACAR_UNKNOWN, GOBP_CILIUM_MOVEMENT, GOBP_CILIUM_OR_FLAGELLUM_DEPENDENT_CELL_MOTILITY, GOBP_DEVELOPMENTAL_PROCESS_INVOLVED_IN_REPRODUCTION, GOCC_PROTEIN_DNA_COMPLEX, GSE13762_CTRL_VS_125_VITAMIND_DAY5_DC_UP, ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_DN, ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY, NRL_DN.V1_UP
GO Biological Process (4): spermatogenesis (GO:0007283), cell differentiation (GO:0030154), chromosome condensation (GO:0030261), flagellated sperm motility (GO:0030317)
GO Molecular Function (1): DNA binding (GO:0003677)
GO Cellular Component (4): nucleosome (GO:0000786), nucleus (GO:0005634), cytoplasm (GO:0005737), chromosome (GO:0005694)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| developmental process involved in reproduction | 1 |
| male gamete generation | 1 |
| cellular developmental process | 1 |
| chromosome organization | 1 |
| cilium-dependent cell motility | 1 |
| cilium movement involved in cell motility | 1 |
| sperm motility | 1 |
| nucleic acid binding | 1 |
| chromatin | 1 |
| protein-DNA complex | 1 |
| intracellular membrane-bounded organelle | 1 |
| intracellular anatomical structure | 1 |
| cellular anatomical structure | 1 |
| intracellular membraneless organelle | 1 |
Protein interactions and networks
STRING
362 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| PRM3 | PRM2 | P04554 | 815 |
| PRM3 | TNP2 | Q05952 | 808 |
| PRM3 | TNP1 | P09430 | 681 |
| PRM3 | PRM1 | P04553 | 541 |
| PRM3 | ROMO1 | P60602 | 490 |
| PRM3 | BRDT | Q58F21 | 452 |
| PRM3 | TMEM225 | Q6GV28 | 451 |
| PRM3 | HADHB | P55084 | 418 |
| PRM3 | TBXA2R | P21731 | 415 |
| PRM3 | IZUMO3 | Q5VZ72 | 412 |
| PRM3 | TMEM225B | P0DP42 | 407 |
| PRM3 | SPACA3 | Q8IXA5 | 404 |
| PRM3 | TSSK6 | Q9BXA6 | 400 |
| PRM3 | SYCP1 | Q15431 | 396 |
| PRM3 | SOX30 | O94993 | 384 |
IntAct
2 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| PRM3 | ARRB2 | psi-mi:“MI:0914”(association) | 0.350 |
ESM2 similar proteins: A0A0U1RQG5, A1L429, A6NDE8, A6NER3, A6NGK3, E1AZ71, O08664, O60829, O75459, O76087, P0C2W7, P0CL80, P0CL81, P0CL82, P0DSO3, P0DTW1, P52651, P62521, P86478, P86479, P86480, P86481, P86496, Q13066, Q13069, Q13070, Q17QW4, Q28181, Q2T9P9, Q32PA2, Q4V321, Q4V326, Q5JQC4, Q5U2Y8, Q62100, Q63803, Q64256, Q6NT46, Q6X7S9, Q7Z2X7
Diamond homologs: Q32PA2, Q62100, Q64256, Q9NNZ6
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
28 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 23 |
| Likely benign | 2 |
| Benign | 3 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
110 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 16:11273441:T:TA | donor_gain | 0.8800 |
| 16:11273481:CA:C | donor_gain | 0.8600 |
| 16:11273470:AT:A | donor_gain | 0.7800 |
| 16:11273348:T:TA | donor_gain | 0.7500 |
| 16:11273480:A:AC | donor_gain | 0.7500 |
| 16:11273481:C:CC | donor_gain | 0.7500 |
| 16:11273471:T:TA | donor_gain | 0.7300 |
| 16:11273345:T:TA | donor_gain | 0.6800 |
| 16:11273264:T:TA | donor_gain | 0.6500 |
| 16:11273448:CCG:C | acceptor_gain | 0.6500 |
| 16:11273449:CGC:C | acceptor_gain | 0.6500 |
| 16:11273606:G:A | donor_gain | 0.6500 |
| 16:11273447:CCCG:C | acceptor_gain | 0.6400 |
| 16:11273448:CCGC:C | acceptor_gain | 0.6400 |
| 16:11273380:G:A | donor_gain | 0.6000 |
| 16:11273563:G:A | donor_gain | 0.5900 |
| 16:11273451:C:CC | acceptor_gain | 0.5800 |
| 16:11273333:T:TA | donor_gain | 0.5700 |
| 16:11273449:CG:C | acceptor_gain | 0.5600 |
| 16:11273602:CG:C | donor_gain | 0.5400 |
| 16:11273449:C:T | acceptor_gain | 0.5300 |
| 16:11273603:G:C | donor_gain | 0.5200 |
| 16:11273449:CGCT:C | acceptor_loss | 0.4900 |
| 16:11273450:GCTG:G | acceptor_loss | 0.4900 |
| 16:11273451:CTGAT:C | acceptor_loss | 0.4900 |
| 16:11273452:T:C | acceptor_loss | 0.4900 |
| 16:11273481:CACAG:C | donor_gain | 0.4900 |
| 16:11273446:G:A | donor_gain | 0.4800 |
| 16:11273454:A:AC | acceptor_gain | 0.4800 |
| 16:11273225:T:TA | donor_gain | 0.4600 |
AlphaMissense
675 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 16:11273498:T:A | K33I | 0.918 |
| 16:11273476:A:C | S40R | 0.910 |
| 16:11273476:A:T | S40R | 0.910 |
| 16:11273478:T:G | S40R | 0.910 |
| 16:11273471:T:A | D42V | 0.884 |
| 16:11273497:T:A | K33N | 0.874 |
| 16:11273497:T:G | K33N | 0.874 |
| 16:11273484:A:G | C38R | 0.861 |
| 16:11273464:G:C | F44L | 0.846 |
| 16:11273464:G:T | F44L | 0.846 |
| 16:11273466:A:G | F44L | 0.846 |
| 16:11273482:A:C | C38W | 0.835 |
| 16:11273492:A:G | L35P | 0.833 |
| 16:11273483:C:T | C38Y | 0.822 |
| 16:11273472:C:G | D42H | 0.818 |
| 16:11273471:T:G | D42A | 0.808 |
| 16:11273483:C:G | C38S | 0.799 |
| 16:11273484:A:T | C38S | 0.799 |
| 16:11273375:A:G | L74P | 0.797 |
| 16:11273583:A:G | C5R | 0.786 |
| 16:11273581:A:C | C5W | 0.779 |
| 16:11273372:A:G | L75P | 0.771 |
| 16:11273498:T:G | K33T | 0.766 |
| 16:11273459:A:G | L46S | 0.760 |
| 16:11273582:C:G | C5S | 0.758 |
| 16:11273583:A:T | C5S | 0.758 |
| 16:11273492:A:T | L35H | 0.757 |
| 16:11273375:A:T | L74Q | 0.748 |
| 16:11273465:A:G | F44S | 0.740 |
| 16:11273500:C:A | M32I | 0.737 |
dbSNP variants (sampled 300 via entrez): RS1000007335 (16:11273201 C>A), RS1001674418 (16:11274026 C>T), RS1002046271 (16:11274712 G>T), RS1002111087 (16:11273880 A>G), RS1002416832 (16:11274926 C>G), RS1003890829 (16:11274886 T>C), RS1004532263 (16:11274706 T>A), RS1005190632 (16:11273950 G>A), RS1005468394 (16:11274168 T>C), RS1006370777 (16:11272733 T>C), RS1007867149 (16:11274304 C>T), RS1008097954 (16:11275083 C>T), RS1008374860 (16:11274429 C>A,T), RS1009984706 (16:11274081 C>A), RS1010415324 (16:11274280 A>G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
8 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST000258_5 | Type 1 diabetes | 3.000000e-06 |
| GCST001341_12 | Multiple sclerosis | 6.000000e-07 |
| GCST001958_14 | Bulimia nervosa | 2.000000e-06 |
| GCST003268_27 | Psoriasis vulgaris | 3.000000e-07 |
| GCST004131_115 | Inflammatory bowel disease | 1.000000e-06 |
| GCST004132_39 | Crohn’s disease | 1.000000e-07 |
| GCST005527_32 | Psoriasis | 5.000000e-08 |
| GCST009798_15 | Asthma | 2.000000e-33 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:1001494 | psoriasis vulgaris |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
3 total (human), top 3 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Acetaminophen | decreases expression | 1 |
| Benzo(a)pyrene | affects methylation, decreases methylation | 1 |
| Valproic Acid | increases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): bulimia nervosa, multiple sclerosis, psoriasis, type 1 diabetes mellitus